Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.
CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.
CLC bio is expanding in both North and South America with the opening of a new location in Boston, MA and a new Government Sector Branch in the Washington, D.C. area.